Overall Technical outlook

Price Summary

On 2026-07-01, AUROPHARMA's stock opened at 1578.7, reached a peak of 1588.7, dropped to 1549.7, and ended -1.65% down at 1552.6, with a volume of 590132 shares.
Over the previous 52 weeks, the stock reached a high of 1578.7 and a low of 1022.2.

Technicals

Support and Resistance: At 1552.6, the price for AUROPHARMA is supported at 1546.7 and resisted at 1546.7. This indicates a trading range where 1546.7 serves as a support level, potentially preventing further decline, while 1546.7 could limit upward movement.
AUROPHARMA supportResistance 6ba43a
Support/Resistance for AUROPHARMA


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
AUROPHARMA aroon 6ba43a
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral for AUROPHARMA, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
AUROPHARMA bbands 6ba43a
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
AUROPHARMA psar 6ba43a
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The K-line has slipped below the D-line on the stochastic indicator while staying above 80, suggesting the onset of a bearish price move. This pattern may indicate that the market's upward momentum is starting to fade, which could lead to a reversal. Investors should be mindful of this possible shift for AUROPHARMA.
AUROPHARMA stoch 6ba43a
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the wavering slopes of the 20 and 50 SMAs indicate that this momentum is weakening. This could be an early sign that the market is preparing for a bullish reversal, as the current downward trend begins to lose steam. Investors may soon see a shift towards more positive price action as the trend starts to change.
AUROPHARMA trippleSMA 6ba43a
Tripple SMA chart for Aurobindo Pharma Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.